April 18, 2024
University of Pennsylvania
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved.
document
adverse events,COVID-19,lipid nanoparticles,vaccine composition,vaccine systemic and virological concerns,vaccines